In this review, we summarize the possible mechanisms of COVID-19-associated coagulopathy and compare its features to other similar conditions The recent CO-VID-19 pandemic has caused enormous mortality and morbidity worldwide It is important to note that CO-VID-19-associated thrombotic events play a huge role in the morbidity of this disease Interestingly, it has been observed that this complication may occur de-spite prophylactic anticoagulant therapy Recent stud-ies on COVID-19-associated coagulopathy revealed that the COVID-19-associated hypercoagulability is more frequently observed among those with a severe course of the disease Various mechanisms have been suggested as explanations for this condition and possible underlying etiologies © 2021, EDIMES Edizioni Medico Scientifiche All rights reserved
Covid-19-associated coagulopathy: A concise review on pathogenesis and clinical implications